Benyam Muluneh, PharmD, BCOP
bmuluneh.bsky.social
Benyam Muluneh, PharmD, BCOP
@bmuluneh.bsky.social
Assistant Professor at UNC Eshelman School of Pharmacy. #adherence, #cancer, #globalhealth, #access, #impsci, #equity
Reposted by Benyam Muluneh, PharmD, BCOP
🚨 1 in 6 cancer meds in sub-Saharan Africa failed quality tests. ISOPP & UICC urge global action to ensure safe, effective treatment. “This highlights supply chain vulnerabilities,” says Dr Benyam Muluneh. 🔗 Full statement www.isopp.org/article/isop... #CancerCare #MedicineSafety #GlobalHealthEquity
July 8, 2025 at 5:54 PM
Check out our latest article on @lancetgh.bsky.social

🚩 1 in 6 chemotherapy products tested in LMIC settings failed assay🚩

This work was possible thanks to funding from @NIH & our in-country PIs. Thank you Dr. Marya Lieberman for your amazing leadership!

www.thelancet.com/journals/lan...
Substandard anticancer medications in clinical care settings and private pharmacies in sub-Saharan Africa: a systematic pharmaceutical investigation
Oncology practitioners and health systems in sub-Saharan Africa need to be aware of the possible presence of substandard anticancer products when designing care protocols and evaluating patient outcom...
www.thelancet.com
June 26, 2025 at 3:20 AM
Reposted by Benyam Muluneh, PharmD, BCOP
"U.S.A.I.D. employees, who mostly joined the agency in hopes of making the world a better place, are in agony," our columnist @nickkristof.bsky.social writes. "'We're just paralyzed,' an agency employee in Africa told me. 'No one is in charge.'"
Opinion | It’s America That Suffers When We Cut Foreign Aid
U.S.A.I.D. keeps children alive and us safe.
www.nytimes.com
February 12, 2025 at 11:20 PM
youtube.com
February 11, 2025 at 6:30 PM
“Oddly silent.”
Some higher ed organizations who are loudly circling the wagons against federal funding cuts were oddly silent or circumspect about the earlier attacks on CRT and DEI.

I wish there was a better understanding that these attacks are coming because we failed to repel those.
February 11, 2025 at 4:46 PM
Reposted by Benyam Muluneh, PharmD, BCOP
Hospitals that can afford Super Bowl ads shouldn’t be sending their patients to collections
So what do my HCW friends think about NYU Langone spending millions of dollars in the Super Bowl for an ad instead of say paying more to their workers or buy new equipment?
Good use of resources? 🤔
February 10, 2025 at 2:37 AM
🚨
Here's a lesson for all of us that the universities are relearning today:
Staying silent in the face of fascism will not protect you.
February 8, 2025 at 5:09 PM
Reposted by Benyam Muluneh, PharmD, BCOP
If you oppose DEI you should have to use the full phrase, “I oppose diversity, equity and inclusion.”

Bonus points if you add your points, “I oppose disabled veterans equal access to employment.” “I oppose mothers having jobs.”

Making it an acronym turns it into a thought-terminating cliche.
February 5, 2025 at 6:48 PM
Reposted by Benyam Muluneh, PharmD, BCOP
🚨BREAKING. From a program officer at the National Science Foundation, a list of keywords that can cause a grant to be pulled. I will be sharing screenshots of these keywords along with a decision tree. Please share widely. This is a crisis for academic freedom & science.
February 4, 2025 at 1:26 AM
This.
i think it is important to say that the open and explicit racism of the president and the vice president isn’t just uncouth or “controversial” but a direct attack on tens of millions of americans and a dereliction of their duty to represent the entire country
January 31, 2025 at 2:01 AM
Reposted by Benyam Muluneh, PharmD, BCOP
As we watch all mention of diversity actively get scrubbed from the NIH website in real time it's important to know that, we were not taking over anything, we were just trying to exist.
- Only 2% of NIH R01 grants are awarded to Black investigators.
The goal is total erasure/elimination.
January 30, 2025 at 8:31 PM
Reposted by Benyam Muluneh, PharmD, BCOP
There’s no reason that we can’t have federal health leadership that wants children to have both healthy food & vaccines. They aren’t mutually exclusive 🧐
December 17, 2024 at 4:16 PM
Reposted by Benyam Muluneh, PharmD, BCOP
Writing isn't what you do after you have an idea. It's how you develop an inkling into an insight.

Turning thoughts into words sharpens reasoning. What's fuzzy in your head is clear on the page.

"I'm not a writer" shouldn't stop you from writing. Writing is a tool for thinking.
December 15, 2024 at 2:00 PM
Reposted by Benyam Muluneh, PharmD, BCOP
Staggering statistics at #ASH24 #TreatingFairly

Patients with cancer who go bankrupt are nearly 80% more likely to die regardless of disease status.

Our system quite literally kills people.
December 8, 2024 at 12:17 AM
Reposted by Benyam Muluneh, PharmD, BCOP
Finally out- our study of travel burdens and health system factors and rural-dwelling adults' breast, cervical, and colorectal cancer screening receipt link.springer.com/article/10.1...
Longer travel times to acute hospitals are associated with lower likelihood of cancer screening receipt among rural-dwelling adults in the U.S. South - Cancer Causes & Control
Purpose Given rural hospitals’ role in providing outpatient services, we examined the association between travel burdens and receipt of cancer screening among rural-dwelling adults in the U.S. South r...
link.springer.com
November 22, 2024 at 1:26 PM
Excited to present all the hard work of my spectacular team at #ESPACOMP24

Thankful for the #NIH for funding this work.

💊We now understand the gaps and solutions offered by patients with cancer
💡Next, we will be developing an intervention to support patients on oral oncolytics.
November 21, 2024 at 12:37 PM
Non-adherence in cancer continues to be a major gap.
#ESPACOMP24
November 21, 2024 at 11:33 AM
ABC Taxonomy on the phases of #adherence

#ESPACOMP24
November 21, 2024 at 11:16 AM
US Audience member: does cost matter for these patients in impacting #adherence?

European presenter: no, cost doesn’t matter.
November 21, 2024 at 9:32 AM
Implementation Science 🤝 Adherence intervention development
November 21, 2024 at 8:32 AM
Excited to be at my first in-person #ESPACOMP (International Society for Med Adherence) conference.
November 21, 2024 at 8:15 AM
Reposted by Benyam Muluneh, PharmD, BCOP
Europeans: Thanks for your email. I’m on vacation so as you read this response, the email you sent is disappearing into thin air, never to be read by human eyes.

Americans: My sincerest apologies. The infant I am birthing is currently crowning but not to worry, I will get back to you momentarily.
November 20, 2024 at 6:39 PM
Their emergency ≠ Your emergency.
Daily reminder: it’s ok to ignore those email/requests that come to you with a false sense of urgency.
Ignore it. Don’t let these things ruin your day.
November 19, 2024 at 7:04 PM
Reposted by Benyam Muluneh, PharmD, BCOP
I big step for those of us that fight against AML alongside our amazing patients. The first menin inhibitor gets FDA approval today! Huge congrats to all of those that worked hard to bring this to fruition to allow more options for this terrible disease.

www.fda.gov/drugs/resour...
FDA approves revumenib for relapsed or refractory acute leukemia
On November 15, 2024, the FDA approved revumenib (Revuforj, Syndax Pharmaceuticals, Inc.) for relapsed or refractory acute leukemia with a KMT2A translocation.
www.fda.gov
November 16, 2024 at 2:11 AM
Reposted by Benyam Muluneh, PharmD, BCOP
Open enrollment got you in a panic about affording your meds next year? Great tips below to help!

If you are on Medicare, your best bet is to shop for a plan before December 7th. No reason to overpay and most people don't shop! Can make a big difference at the pharmacy counter!
benro.me Ben Rome @benro.me · Nov 16
How can clinicians help their patients afford costly medications?? 💊💰

In a recent JAMA review, we outlined an algorithm and talk about the pros and cons of several options, including copay cards, pharmacy coupons, and more.

#Medsky 🩺📊
@portalresearch.bsky.social

jamanetwork.com/journals/jam...
November 16, 2024 at 3:28 PM